Adaptimmune Therapeutics PLC
NASDAQ:ADAP
Adaptimmune Therapeutics PLC
NASDAQ:ADAP
Price:
1.02 USD
-0.97%
Market Closed
Updated:
Jun 9, 2024
Adaptimmune Therapeutics PLC
Intangible Assets
|
Adaptimmune Therapeutics PLC
Intangible Assets Peer Comparison
Comparables:
CNTA
AUTL
BCYC
IMCR
GNS
Competitive Intangible Assets Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Intangible Assets | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Adaptimmune Therapeutics PLC
NASDAQ:ADAP
|
Intangible Assets
$524k
|
CAGR 3-Years
-31%
|
CAGR 5-Years
-19%
|
CAGR 10-Years
N/A
|
|
|
Centessa Pharmaceuticals PLC
NASDAQ:CNTA
|
Intangible Assets
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Autolus Therapeutics PLC
NASDAQ:AUTL
|
Intangible Assets
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Bicycle Therapeutics PLC
NASDAQ:BCYC
|
Intangible Assets
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Immunocore Holdings PLC
NASDAQ:IMCR
|
Intangible Assets
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Genus PLC
LSE:GNS
|
Intangible Assets
£67.5m
|
CAGR 3-Years
-1%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
0%
|
See Also
What is Adaptimmune Therapeutics PLC's Intangible Assets?
Intangible Assets
524k
USD
524k
USD
Based on the financial report for Mar 31, 2024, Adaptimmune Therapeutics PLC's Intangible Assets amounts to 524k USD.
What is Adaptimmune Therapeutics PLC's Intangible Assets growth rate?
Intangible Assets CAGR 5Y
-19%
-19%
Over the last year, the Intangible Assets growth was 31%. The average annual Intangible Assets growth rates for Adaptimmune Therapeutics PLC have been -31% over the past three years , -19% over the past five years .
You don't have any saved screeners yet
